Armistice Capital’s Medigus Ltd. Series C Warrant MDGSW Stock Holding History

Armistice Capital’s Portfolio MDGSW Stock Details MDGSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-85,714	Closed	-$5.06K	–	303
2023 Q2	$5.06K	Sell	85,714 -1	-0%	–	﹤0.01%	215
2023 Q1	$2.53K	Buy	85,715 +1	+0%	–	﹤0.01%	223
2022 Q4	$12.9K	Sell	85,714 -1,200,001	-93%	-$203K	﹤0.01%	188
2022 Q3	$129K	Hold	1,285,715	–	–	﹤0.01%	173
2022 Q2	$318K	Hold	1,285,715	–	–	0.01%	147
2022 Q1	$386K	Hold	1,285,715	–	–	0.01%	122
2021 Q4	$270K	Hold	1,285,715	–	–	﹤0.01%	140
2021 Q3	$745K	Hold	1,285,715	–	–	0.01%	126
2021 Q2	$720K	Hold	1,285,715	–	–	0.01%	109
2021 Q1	$1.11M	Hold	1,285,715	–	–	0.03%	102
2020 Q4	$1.09M	Hold	1,285,715	–	–	0.04%	99
2020 Q3	$634K	Buy	+1,285,715	New	+$265K	0.02%	97
2019 Q3	–	Sell	-1,285,715	Closed	-$1.53M	–	86
2019 Q2	$1.53M	Hold	1,285,715	–	–	0.1%	58
2019 Q1	$2.04M	Hold	1,285,715	–	–	0.11%	64
2018 Q4	$1.75M	Buy	+1,285,715	New	+$874K	0.13%	57

Armistice Capital's MDGSW Position: Q3 2023 in Review

Armistice Capital sold out of Medigus Ltd. Series C Warrant (MDGSW) in Q3 2023, closing a stake of 85,714 shares — an estimated $5.06K sold.

Armistice Capital first reported a position in MDGSW in Q4 2018 and held it in 15 quarters. The position peaked at $2.04M in Q1 2019. 0 funds tracked by Wall St. Rank hold MDGSW as of Q3 2023.

Armistice Capital reported no remaining Medigus Ltd. Series C Warrant position as of Q3 2023 after selling out during the quarter.
Armistice Capital sold 85,714 Medigus Ltd. Series C Warrant shares in Q3 2023, an estimated $5.06K.
Armistice Capital first reported a position in Medigus Ltd. Series C Warrant in Q4 2018 and held it in 15 quarters.
Armistice Capital's Medigus Ltd. Series C Warrant position peaked at $2.04M in Q1 2019.
0 funds tracked by Wall St. Rank held Medigus Ltd. Series C Warrant as of Q3 2023.

Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.